Table 1 Demographic and clinicopathological characteristics of patient cohort
Variable | Total | |
|---|---|---|
Patients, number | 47 | |
Age, years | 70.4 ± 9.4 | |
Sex | Men | 41 (87.2%) |
Women | 6 (12.8%) | |
Body mass index, kg/m2 | 19.9 ± 3.1 | |
Histopathology, n (%) | ||
Squamous cell carcinoma | 41 (87.2%) | |
Others | 6 (12.8%) | |
Primary tumour location, n (%) | ||
Cervical | 2 (4.3%) | |
Thoracic | 36 (76.6%) | |
Abdominal | 9 (19.2%) | |
Pathological stage, n (%) | ||
I | 26 (55.3%) | |
II | 13 (27.7%) | |
III | 8 (17.0%) | |
Pre-operative chemotherapy | 7 (14.9%) | |
Pre-operative radiotherapy | 2 (4.3%) | |
Adjuvant chemotherapy | 28 (59.6%) | |
Operation time, min | 456.7 ± 62.9 | |
Intra-operative blood loss, mL | 158.2 ± 192.3 | |
Diabetes mellitus | 6 (12.8%) | |
Current smoking | 25 (53.2%) | |
Sarcopenia | 19 (40.4%) | |
HALS | 17 (36.2%) | |
Complete laparoscopic surgery | 27 (57.4%) | |
Robot assisted surgery | 3 (6.4%) | |
Pneumonia | 12 (25.3%) | |
Anastomotic leakage | 7 (14.8%) | |
Ileus | 6 (12.8%) | |
RLNP | 12 (25.5%) | |
Refractory enterocutaneous fistula | 15 (31.9%) | |
Recurrence | 9 (19.2%) | |
Death | 11 (23.4%) | |
Length of fistula, mm | 16.3 ± 6.4 | |
Duration for removal jejunostomy, months | 12.6 ± 7.0 | |